Company news

Tarsus Pharmaceuticals, Inc. news in 2023

Tarsus Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Tarsus Announces Positive Topline Results from the Ersa Phase 2a Clinical Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease in Patients with Demodex Mites

December 10, 2023

Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements

November 8, 2023

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

October 31, 2023

Tarsus to Ring Nasdaq Stock Market Closing Bell in Celebration of the Launch of XDEMVY™, the First and Only FDA Approved Treatment for Demodex Blepharitis

September 5, 2023

Tarsus to Present at Upcoming Investor Conferences

August 29, 2023

Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis

August 23, 2023

Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements

August 9, 2023

Tarsus Announces Pricing of $100.0 Million Underwritten Public Offering of Common Stock

July 31, 2023

Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of Shares of its Common Stock

July 30, 2023

FDA Approves XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis

July 24, 2023

Tarsus to Host Virtual Investor Webcast Highlighting the Commercialization Strategy, Plans and Progress for TP-03, Its Potential Treatment for Demodex Blepharitis

June 11, 2023

Tarsus to Present at the Jefferies Global Healthcare Conference

June 4, 2023

Tarsus Reports First Quarter 2023 Financial Results and Recent Business Achievements

May 8, 2023

Tarsus Launches “Don’t Freak Out. Get Checked Out.” Campaign During Healthy Vision Month to Encourage Patients with Demodex Blepharitis to Visit Eye Care Providers

May 7, 2023

Tarsus to Participate at the Bank of America 2023 Healthcare Conference

May 2, 2023

Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer

April 23, 2023

Tarsus Reports Full-Year 2022 Financial Results and Recent Business Achievements

March 12, 2023

Calls in 2023

Decks in 2023